Amrize Ltd $AMRZ Stake Raised by Kailix Advisors LLC

Kailix Advisors LLC boosted its holdings in shares of Amrize Ltd (NYSE:AMRZ) by 50.4% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 205,450 shares of the company’s stock after purchasing an additional 68,870 shares during the quarter. Amrize comprises 13.6% of Kailix Advisors LLC’s portfolio, making the stock its 5th biggest position. Kailix Advisors LLC’s holdings in Amrize were worth $9,970,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in AMRZ. State of Wyoming purchased a new position in shares of Amrize during the third quarter worth $32,000. Costello Asset Management INC acquired a new stake in Amrize during the 3rd quarter worth about $44,000. Global Retirement Partners LLC purchased a new position in shares of Amrize during the 3rd quarter valued at about $48,000. Jones Financial Companies Lllp purchased a new position in shares of Amrize during the 3rd quarter valued at about $53,000. Finally, BNP Paribas Financial Markets acquired a new position in shares of Amrize in the 2nd quarter valued at about $59,000.

Insider Activity

In related news, Director Nicholas C. Gangestad bought 2,000 shares of the business’s stock in a transaction dated Wednesday, November 19th. The stock was acquired at an average price of $47.34 per share, with a total value of $94,680.00. Following the completion of the purchase, the director directly owned 4,958 shares of the company’s stock, valued at approximately $234,711.72. This trade represents a 67.61% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.

Amrize Price Performance

Amrize stock opened at $58.86 on Friday. The stock has a market capitalization of $32.55 billion and a P/E ratio of 31.99. The company’s fifty day moving average price is $55.38 and its 200 day moving average price is $52.12. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.97 and a current ratio of 1.45. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $60.57.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. Vertical Research initiated coverage on Amrize in a research report on Tuesday, November 25th. They set a “hold” rating and a $54.00 price target for the company. Morgan Stanley set a $61.00 target price on shares of Amrize and gave the company an “overweight” rating in a report on Wednesday, October 29th. Royal Bank Of Canada cut shares of Amrize from an “outperform” rating to a “sector perform” rating and boosted their target price for the company from $56.00 to $60.00 in a research note on Monday, December 8th. Weiss Ratings upgraded shares of Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday. Finally, Wells Fargo & Company upped their price objective on shares of Amrize from $58.00 to $59.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Amrize has a consensus rating of “Moderate Buy” and an average target price of $60.75.

Amrize Company Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.